AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3230146
Drug: A-56234 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A-56234 at 40 mg
Trial: 3230146
Drug: A-56234 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A-56234 at 60 mg
Trial: 3230146
Drug: A-56234 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A-56234 at 80 mg
Trial: 12046816
Drug: Topical calcipotriol
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical calcipotriol monotherapy
Trial: 30005743
Drug: Atorvastatin (lipophilic)
DrugBank: Atorvastatin (DB01076)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atorvastatin (lipophilic)
Trial: 18297975
Drug: Pharmacotherapy trials
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacotherapy trials
Trial: 18297975
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of psychotherapy and pharmacotherapy trials
Trial: 16802855
Drug: Oxycodone 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone 0.2 mg/kg buccally
Trial: 16802855
Drug: Oxycodone 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone 0.2 mg/kg sublingually
Trial: 14711140
Drug: Intravenous alefacept
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous alefacept
Trial: 10836009
Drug: Curative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curative treatment for hepatic malignancies
Trial: 10836009
Drug: Investigational therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Investigational therapies for hepatic malignancies
Trial: 1565349
Drug: Ibuprofen, 600
RxNorm normalized name: Ibuprofen, 600 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen, 600 mg
Trial: 6323378
Drug: Oral mecillinam
RxNorm normalized name: mecillinam
DrugBank: Amdinocillin (DB01163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral mecillinam
Trial: 29525763
Drug: Pilates twice
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pilates twice a week (PG2)
Trial: 29525763
Drug: Pilates twice
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pilates twice a week (PG2) vs Pilates once a week (PG1)
Trial: 27154357
Drug: LY +
RxNorm normalized name: Thrifty White One Daily + Iron Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY + SUN (LY2510924 20 mg SC daily + Sunitinib 50 mg PO daily for 4 weeks followed by 2 weeks off)
Trial: 27154357
Drug: SUN (Sunitinib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SUN (Sunitinib 50 mg PO daily for 4 weeks followed by 2 weeks off)
Trial: 11808937
Drug: Initial phlebotomy
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial phlebotomy to reduce serum ferritin levels to 10 ng/ml or less followed by maintenance phlebotomy for 5 years
Trial: 10411862
Drug: Lovastatin +
RxNorm normalized name: Lovastatin
DrugBank: Lovastatin (DB00227)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lovastatin + warfarin combination
Trial: 8635022
Drug: Lipiodol-epirubicin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipiodol-epirubicin (75 mg/m2)
Trial: 2073669
Drug: Lovastatin (final
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin (final average dose 70.5 mg/day)
Trial: 6845976
Drug: THIP (4,5,6,7‐tetrahydroisoxazolo(5,4‐c)pyridin‐3‐ol)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: THIP (4,5,6,7‐tetrahydroisoxazolo(5,4‐c)pyridin‐3‐ol) at doses of 15 to 120 mg/day
Trial: 6845976
Drug: THIP (submaximal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: THIP (submaximal doses)
Trial: 29562558
Drug: Conventional dysphagia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional dysphagia treatment
Trial: 27627193
Drug: Omarigliptin 10
RxNorm normalized name: Omarigliptin
DrugBank: Omarigliptin (DB11992)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Omarigliptin 10 mg
Trial: 24724807
Drug: High-dose folic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose folic acid (5 mg/day)
Trial: 22998754
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 supplementation (25 μg per day as cholecalciferol)
Trial: 22998754
Drug: Placebo (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (25 μg per day as lactose)
Trial: 21051846
Drug: Gynoflor® (lyophilized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gynoflor® (lyophilized lactobacilli and 0.03 mg estriol)
Trial: 21051846
Drug: Metronidazole (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (500 mg vaginal suppositories)
Trial: 17417917
Drug: Rabeprazole (RPZ)
DrugBank: Rabeprazole (DB01129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rabeprazole (RPZ) 20 mg daily plus Clarithromycin (Cla) 500 mg b.d. and Amoxicillin (Am) 1,000 mg b.d. for 7 days
Trial: 17417917
Drug: Rabeprazole (RPZ)
DrugBank: Rabeprazole (DB01129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rabeprazole (RPZ) 20 mg daily plus Clarithromycin (Cla) 500 mg b.d. and Amoxicillin (Am) 1,000 mg b.d. for 14 days
Trial: 15244246
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with cyclophosphamide, methotrexate, or 5-fluorouracil (CMF)
Trial: 11031403
Drug: 1 week
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 1 week of antibiotics and a chemical matrixectomy simultaneously (group 1)
Trial: 11031403
Drug: Antibiotics for
RxNorm normalized name: ANTIBIOTICS FOR TOPICAL USE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics for 1 week and then a matrixectomy (group 2)
Trial: 2869001
Drug: atenolol 100
RxNorm normalized name: atenolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atenolol 100 mg once a day
Trial: 2869001
Drug: oxprenolol 80
RxNorm normalized name: oxprenolol 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oxprenolol 80 mg twice a day
Trial: 2869001
Drug: nadolol 80
RxNorm normalized name: nadolol 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nadolol 80 mg once a day
Trial: 29378991
Drug: IV tramadol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV tramadol 100 mg (Group BT)
Trial: 29378991
Drug: IV dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: IV dexamethasone 8 mg (Group BD)
Trial: 21227563
Drug: 6 min
RxNorm normalized name: garlic 6 minim ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 min of monthly practice on a voice advisory manikin
Trial: 18497677
Drug: Single-dose rATG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose rATG (6 mg/kg)
Trial: 18497677
Drug: Divided doses
RxNorm normalized name: Aluminum Zirconium Trichlorohydrex Gly 20 g in 100 g TOPICAL STICK [Dividends]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Divided doses rATG (1.5 mg/kg every other day for 4 days)
Trial: 10960528
Drug: AS-24 (hypotonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AS-24 (hypotonic storage solution)
Trial: 10960528
Drug: AS-3 (control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AS-3 (control storage solution)
Trial: 8977678
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy (PDT) using a portable desktop lamp with 300 W xenon short arc discharge source and topical 5-aminolaevulinic acid (5-ALA) applied 4 hours before irradiation, 125 J/cm2 at a fluence rate of 70 mW/cm2.
Trial: 1309410
Drug: Nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nedocromil sodium 2% ophthalmic solution, administered twice daily
Trial: 30179056
Drug: Concurrent cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent cisplatin (40 mg m‐2) with bowel sparing IMRT (50 Gy/25#/5 wks)
Trial: 30179056
Drug: Bone marrow
RxNorm normalized name: bone marrow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone marrow dose volume constraints
Trial: 26531052
Drug: Mydrane (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mydrane (200 μL of a combination of tropicamide 0.02%, phenylephrine 0.31% and lidocaine 1%)
Trial: 26531052
Drug: Topical regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical regimen (one drop each of tropicamide 0.5% and phenylephrine 10% repeated three times)
Trial: 24781517
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg nicotine oral soluble film
Trial: 19535699
Drug: Helium inhalation
RxNorm normalized name: helium Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Helium inhalation at an end-tidal concentration of 50 vol% during ischemia-reperfusion
Trial: 19535699
Drug: Helium inhalation
RxNorm normalized name: helium Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Helium inhalation at an end-tidal concentration of 50 vol%
Trial: 19535699
Drug: Control (absence
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (absence of helium inhalation)
Trial: 9435773
Drug: Anti-epileptic medication
RxNorm normalized name: pramoxine hydrochloride Medicated Pad [Scalpicin Anti-Itch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-epileptic medication added to existing drug regime
Trial: 31439831
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg oral cannabidiol
Trial: 29263660
Drug: Long-acting β‐2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting β‐2 agonist (LABA)
Trial: 26388284
Drug: Low-sodium PD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-sodium PD solution (125 mmol/L sodium; 1.5%, 2.3%, or 4.25% glucose; osmolarity 338-491 mOsm/L)
Trial: 26388284
Drug: Standard-sodium PD
RxNorm normalized name: PD-0299685
DrugBank: PD-0299685 (DB15264)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-sodium PD solution (134 mmol/L sodium; 1.5%, 2.3%, or 4.25% glucose; osmolarity 356-509 mOsm/L)
Trial: 21719695
Drug: Testosterone supplementation
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone supplementation with testosterone buccal adhesive patches 2 × 30 mg/d for 8 months
Trial: 21719695
Drug: Intraplaque verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraplaque verapamil injections associated with testosterone administration
Trial: 21719695
Drug: Intraplaque verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraplaque verapamil injections associated with a placebo
Trial: 10349044
Drug: Clozapine treatment
RxNorm normalized name: Clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clozapine treatment with akathisia (n = 15)
Trial: 10349044
Drug: Clozapine treatment
RxNorm normalized name: Clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clozapine treatment without akathisia (n = 18)
Trial: 10349044
Drug: Clozapine treatment
RxNorm normalized name: Clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clozapine treatment (both groups)
Trial: 7493423
Drug: Nebulized salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulized salbutamol (5 mg) with hypoxic mixture (FiO2 = 12%)
Trial: 7493423
Drug: Nebulized salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulized salbutamol (5 mg) with normoxic mixture
Trial: 1674394
Drug: Epanolol 100
RxNorm normalized name: epanolol
DrugBank: Epanolol (DB13757)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epanolol 100 mg
Trial: 1674394
Drug: Epanolol 200
RxNorm normalized name: epanolol
DrugBank: Epanolol (DB13757)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epanolol 200 mg
Trial: 1674394
Drug: Epanolol 300
RxNorm normalized name: epanolol
DrugBank: Epanolol (DB13757)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epanolol 300 mg
Trial: 1674394
Drug: Epanolol (pooled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epanolol (pooled data of 3 doses)
Trial: 6765503
Drug: Large doses
RxNorm normalized name: Largemouth bass
DrugBank: Largemouth bass (DB10976)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Large doses of vitamin B6 and magnesium
Trial: 29985978
Drug: Ivermectin-based mass
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ivermectin-based mass drug administration (MDA)
Trial: 29985978
Drug: Ivermectin-based MDA
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ivermectin-based MDA co-administered with azithromycin
Trial: 29985978
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment arm (azithromycin with ivermectin)
Trial: 20224451
Drug: CBEX drink
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CBEX drink (containing total 2 g of carnosine and anserine)
Trial: 1564022
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg dose of methylphenidate
Trial: 15526500
Drug: Mix 25
RxNorm normalized name: Fluclomix 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mix 25 (insulin lispro low mixture)
Trial: 10933350
Drug: L-arginine (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (7 g twice daily)
Trial: 8725472
Drug: Granisetron (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron (2 mg oral dose)
Trial: 30007343
Drug: Mediterranean-like dietary
RxNorm normalized name: insulin-like growth factor 2
DrugBank: Insulin-like growth factor II (DB14472)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mediterranean-like dietary pattern with vitamin D3 (10 µg/d) supplements
Trial: 8659419
Drug: Helical CT
RxNorm normalized name: CT-179
DrugBank: CT-179 (DB17114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Helical CT (HC) acquisition after contrast injection at 6 ml/sec
Trial: 8659419
Drug: Dynamic sequential
RxNorm normalized name: water
DrugBank: Water (DB09145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dynamic sequential CT (DS) acquisition after contrast injection at 2 ml/sec
Trial: 8659419
Drug: Dynamic sequential
RxNorm normalized name: water
DrugBank: Water (DB09145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dynamic sequential CT (DS)
Trial: 1573555
Drug: Neomycin complexed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neomycin complexed on xanthan, administered in a unique daily dose
Trial: 1573555
Drug: Ampicillin or
RxNorm normalized name: ampicillin Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin or furazolidone, administered for 5-10 days or longer
Trial: 3887877
Drug: Sotalol (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotalol (160 mg once daily, increased to 320 mg, 480 mg, and 640 mg if necessary)
Trial: 28791808
Drug: Sonography guided
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sonography guided injection of hyaluronic acid
Trial: 28791808
Drug: Blind injection
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blind injection of hyaluronic acid
Trial: 28791808
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (Sonography guided and Blind injection)
Trial: 18242357
Drug: Ciprofloxacin 400
RxNorm normalized name: ciprofloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 400 mg intravenously and/or 500 mg orally twice daily for 10 days
Trial: 7006476
Drug: Daily administration
RxNorm normalized name: Prevpac 30mg-500mg-500mg Daily Administration Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily administration of isoniazid, rifampin, and ethambutol for 8 weeks, followed by daily for 18 weeks
Trial: 7006476
Drug: Twice weekly
RxNorm normalized name: Alora 0.1 MG/Day Twice Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice weekly administration of isoniazid, rifampin, and ethambutol during the continuation phase
Trial: 7006476
Drug: Once weekly
RxNorm normalized name: Actonel 35 4-Week Once Weekly Dosepack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once weekly administration of isoniazid, rifampin, and ethambutol during the continuation phase
Trial: 7006476
Drug: Twice weekly
RxNorm normalized name: Alora 0.1 MG/Day Twice Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice weekly administration of isoniazid and rifampin during the continuation phase
Trial: 31337958
Drug: NXT15906F6-250 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NXT15906F6-250 mg
Trial: 31337958
Drug: NXT15906F6-400 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NXT15906F6-400 mg
Trial: 27718143
Drug: Donepezil 10
RxNorm normalized name: donepezil 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil 10 mg per day (12h sampling)
Trial: 27718143
Drug: Donepezil 10
RxNorm normalized name: donepezil 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil 10 mg per day (24h sampling)
Trial: 15284371
Drug: Lutein supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lutein supplement
Trial: 15284371
Drug: Lutein ester
RxNorm normalized name: lutein esters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lutein ester supplement
Trial: 10965395
Drug: Promethazine oral
RxNorm normalized name: promethazine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Promethazine oral syrup (50 mg, 10 mL)
Trial: 10965395
Drug: Promethazine rectal
RxNorm normalized name: promethazine Rectal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Promethazine rectal suppository (50 mg)
Trial: 10965395
Drug: Promethazine rectal
RxNorm normalized name: promethazine Rectal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Promethazine rectal suppository (two 12.5 mg)
Trial: 10965395
Drug: Promethazine rectal
RxNorm normalized name: promethazine Rectal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Promethazine rectal suppository (25 mg)
Trial: 10965395
Drug: All formulations
RxNorm normalized name: Novel Influenza-H1N1-09, all formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All formulations (oral syrup and rectal suppositories)
Trial: 10965395
Drug: Three suppository
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three suppository treatments
Trial: 7701651
Drug: Empirical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empirical treatment strategy (group 2)
Trial: 25486391
Drug: Treatment-as-usual Alcohol
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-as-usual Alcohol Diversion Program (ADP)
Trial: 9050948
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose GH: 16 IU/m2/week
Trial: 9050948
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose GH: 28 IU/m2/week
Trial: 9050948
Drug: GH: 24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH: 24 IU/m2/week + Oxa: 0.06 mg/kg/day
Trial: 8466063
Drug: Ketorolac 30
RxNorm normalized name: ketorolac 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 30 mg intramuscularly every 6 h after an initial dose of 60 mg
Trial: 3532404
Drug: Pirprofen (rengasil)
RxNorm normalized name: Carprofen
DrugBank: Pirprofen (DB13722)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pirprofen (rengasil) combined with small doses of corticosteroids
Trial: 26945321
Drug: Higher density
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher density treatment
Trial: 26945321
Drug: Lower density
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower density treatment
Trial: 26945321
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment densities
Trial: 25231953
Drug: Everolimus (EVE)
RxNorm normalized name: Everolimus
DrugBank: Everolimus (DB01590)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Everolimus (EVE) 10 mg/day plus Exemestane (EXE) 25 mg/day
Trial: 25231953
Drug: Placebo (PBO)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PBO) plus Exemestane (EXE) 25 mg/day
Trial: 21164551
Drug: Marine collagen
RxNorm normalized name: marine collagen, soluble
DrugBank: Marine collagen, soluble (DB14246)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marine collagen peptides (MCPs) 13 g daily for 3 months
Trial: 17645254
Drug: Combined auricular
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined auricular and body acupuncture treatment plus moving cupping on back‐shu points